{
    "nctId": "NCT02386371",
    "briefTitle": "Intraoperative Radiotherapy After Local Recurrence in Breast Cancer",
    "officialTitle": "Feasibility Clinical Trial of Intraoperative Radiotherapy (IORT) and Second Breast-conserving-surgery After Local Recurrence of Breast Carcinoma",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Carcinoma",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "NA",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 66,
    "primaryOutcomeMeasure": "The tolerance of RIOP (Intra Operative Radiotherapy) in patients with delayed local recurrences, after a second conservative treatment of breast cancer",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologically proven non-lobular invasive breast recurrence\n* Time from whole breast radiation following the initial lumpectomy \\>5 years\n* Unifocal tumor\n* Recurrent tumor size \u2264 2 cm\n* Adequate breast size for a second breast-conserving surgery with acceptable cosmetic result\n* Bilateral breast mammogram within 90 days prior to study entry\n* Breast MRI within 90 days prior to study entry\n* Histological grade I-II\n* Estrogen-receptor-positive tumor (ER+)\n* Cerb2-negative tumor\n* N0\n* M0\n* Prior radiotherapy delivered within a standard fractionation schedule\n* Performance status (ECOG) 0-1\n* Women \u2265 50 years -Absence of any psychological, familial, sociological, or geographical conditions with a potential to hamper compliance with the study and follow- up schedule\n* Affiliated to the French Health Insurance regimen\n* Written and signed informed consent form.\n\nExclusion Criteria:\n\n* Multifocal and/or multicenter recurrence\n* Lobular carcinoma\n* Estrogen-receptor-negative tumor (ER-)\n* Cerb2 (her2) overexpressed - breast cancer\n* Extensive intraductal component (EIC) on biopsy\n* Lymph vessel invasion on biopsy\n* N1-3 status: Regional cytological or histologically proven node recurrence\n* M1 status: Metastatic disease\n* cT4 (Skin or muscle involvement) or Paget's disease of the nipple\n* Prior radiotherapy delivered within an accelerated or hypo-fraction schedule\n* Prior malignancy other than non-melanoma skin cancer unless the patient has been disease free for at least 5 years\n* Patients with a small breast volume, technically unsatisfactory for a second conservative surgery or intraoperative breast irradiation.\n* Preoperative chemotherapy or hormone therapy for local relapse\n* Connective tissue disease or scleroderma, contraindicating radiotherapy\n* Known BRCA1/2 gene mutation (genetic testing is not required)",
    "sex": "FEMALE",
    "minimumAge": "50 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}